14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego

Denver, CO US
February 6, 2025

The 14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego provides an invaluable educational experience highlighting the latest advances in malignant and non-malignant hematology. Please join us and engage with experts to learn and gain practical insights on current therapies, and innovative treatments. Available on-demand, this activity ensures that health care professionals caring for these patients have unlimited access to the latest scientific updates, innovative ideas, and pressing issues in their field. Participants can gain valuable insights ultimately improving the care and outcomes of patients with hematologic malignancies.

Target Audience

The intended audience is medical oncologists, hematologists and advanced practice providers.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Participants will be able to identify appropriate therapeutic strategies based on the most current evidence, ensuring optimal patient selection for novel treatments in lymphoma, leukemia, and multiple myeloma.
  • Demonstrate an improved ability to anticipate, recognize, and manage toxicities related to therapies, leading to enhanced patient safety and better clinical outcomes.
  • Analyze the latest clinical trial data and FDA- approved therapies for the treatment of hematologic malignancies, including CAR-T therapy, bispecific antibodies, and small-molecule inhibitors.

 

 

 

Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 3.00 Attendance
Course opens: 
10/14/2024
Course expires: 
12/31/2025
Event starts: 
02/06/2025 - 6:00pm MST
Event ends: 
02/06/2025 - 9:00pm MST
Add to calendar: 
Rating: 
0

Thursday, February 6, 2025 | 6:00-9:00 PM (MST)
Empower Field at Mile High | Denver, CO

Download Agenda

Date

SCHEDULEEVENT/TOPICSPEAKER(S)
6:00 - 6:05 PMWelcome & IntroductionJeffrey V. Matous, MD
Colorado Blood Cancer Institute
6:05 - 6:45 PMIndolent LymphomaDai Chiara, MD, PhD
MD Anderson
6:45 - 7:25 PMAggressive LymphomaLoretta Nastoupil, MD
CommonSpirit Oncology Mercy
7:25 - 7:35 PMBreak 
7:35 - 8:15 PMMyeloid NeoplasmsRami Komrokji, MD
Moffitt Cancer Center
8:15 - 8:55 PMMultiple Myeloma and Plasma CellJosh Richter, MD
Mount Sinai
Empower Field at Mile High
1701 Bryant St
Denver, CO 80204
United States
https://www.empowerfieldatmilehigh.com/contact

Course Faculty

Portrait of Casey Gregory

Casey Gregory

Speaker

Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center

Portrait of Rami S. Komrokji, MD

Rami S. Komrokji, MD

Planner

Vice Chair, Malignant Hematology Department, Head of the Leukemia and MDS Section at the Moffitt Cancer Center

Portrait of Jeffrey Matous, MD

Jeffrey Matous, MD

Planner

Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center

Portrait of Yazan Migdady, MD, MSc

Yazan Migdady, MD, MSc

Course Director, Planner

Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center

Portrait of Vicki Snider, RN, BSN, OCN

Vicki Snider, RN, BSN, OCN

Planner

Director of Business Development for Oncology, Presbyterian St. Luke’s Medical Center

Speaker(s)

Dai Chihara, MD, PhD

has a financial relationship (Grant Or Contract) with Genmab;.
has a financial relationship (Grant Or Contract) with Ono;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with Genentech;.

Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 3.00 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose

American Board of Internal Medicine (ABIM) 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

 

Available Credit

  • 3.00 AMA PRA Category 1 Credit™
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 3.00 Attendance
Please login or register to take this course.

Activity Registration Requirements

Learners must have a CME.HealthONEcares.com account in order to access/complete the following requirements. To complete the activity, attendees must...

  1. Participate in the activity
  2. Mark their attendance via SMS code
  3. Complete the Activity Evaluation

Learners who complete the requirements above will receive the designated credits they are eligible for. Learners interested in CME credit must verify their profession is listed in their profile in order to be eligible for credits.

Required Hardware/software

We recommend the following hardware/software to successfully view and complete the contents of this course:

For ease of use, we strongly recommend using a desktop computer to complete this course. The following desktop web browsers are compatible with our system:

Desktop: Chrome, Internet Explorer, MS Edge, Safari

While not recommended, if you are familiar with completing courses online you may complete this course using a mobile device. For those wishing to complete this activity on Mobile, the following systems are recommended:

Apple iPhones and iPad devices on iOS 10 or later
Android phones and tablets on Android OS 4.4 or later using the supported web browsers listed above.

If you encounter any issues while accessing our courses, please contact CME@HealthONEcares.com